Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 10.36
-0.12 (-1.15%)
Jul 21, 2026, 3:00 PM CST
SHA:600380 Market Cap
SHA:600380 has a market cap or net worth of 18.7 billion as of July 21, 2026. Its market cap has decreased by -16.13% in one year.
Market Cap
18.70B
Enterprise Value
16.85B
Revenue
14.85B
Ranking
n/a
PE Ratio
14.40
Stock Price
10.36
ChartMarket Cap Chart
Since June 8, 2001, SHA:600380's market cap has increased from 11.33B to 18.70B, an increase of 65.10%. That is a compound annual growth rate of 2.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 18.70B | -11.48% |
| Dec 31, 2025 | 21.13B | 0.04% |
| Dec 31, 2024 | 21.12B | -8.85% |
| Dec 29, 2023 | 23.17B | 10.03% |
| Dec 30, 2022 | 21.06B | -12.30% |
| Dec 31, 2021 | 24.02B | -10.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jilin Aodong Pharmaceutical Group | 21.76B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.46B |
| Walvax Biotechnology | 21.16B |
| Chengdu Kanghong Pharmaceutical Group | 20.78B |
| Hybio Pharmaceutical | 19.19B |
| Kangmei Pharmaceutical | 18.95B |
| China Resources Double-Crane Pharmaceutical | 17.87B |
| Shandong Buchang Pharmaceuticals | 16.69B |